首页> 中文期刊> 《中国生化药物杂志》 >重组人凝血因子Ⅶ、卡前列素胺丁三醇、心理干预治疗产后出血的临床疗效及其对生活质量的影响

重组人凝血因子Ⅶ、卡前列素胺丁三醇、心理干预治疗产后出血的临床疗效及其对生活质量的影响

             

摘要

Objective To summarize analysis postpartum hemorrhage were treated by human recombinant coagulation factor Ⅶ, CARDS and other three amine butyl alcohol, psychological intervention treatment of clinical effects and the patient's quality of life.Methods Our hospital during July 2013 to December 2016, total 100 cases of postpartum hemorrhage patients treated with the control group of 50 patients with card other three amine butyl alcohol with psychological intervention therapy;observation group of 50 cases using human recombinant coagulation factor Ⅶ, CARDS and other three amine butyl alcohol, psychological intervention treatment, two groups of patients were reviewed treatment effect and postpartum quality of life.Results In the bleeding, bleeding time, postpartum anxiety score, depression score indicators, such as observation group is less than the control group, the difference to be markedly, with statistical significance (P<0.05);In the postpartum life quality score, the observation group is higher than the control group, the obvious differences, statistically significant (P<0.05);In terms of adverse reaction happening, observation group and control group difference is not obvious, not statistically significant .Conclusion Human recombinant coagulation factor Ⅶ, CARDS and other three amine butyl alcohol, psychological intervention treatment of postpartum hemorrhage, the clinical curative effect is distinct, can better improve the patients quality of life, improve patients' negative mood, is worthy of popularization and application.%目的 总结分析产后出血患者采用重组人凝血因子Ⅶ、卡前列素胺丁三醇、心理干预治疗后的临床效果以及患者的生活质量.方法 选取锦州医科大学附属第三医院2013年7月~2016年12月期间共收治产后出血患者100例,其中对照组50例采用卡前列素胺丁三醇联合心理干预治疗;观察组50例采用重组人凝血因子Ⅶ、卡前列素胺丁三醇、心理干预治疗,回顾分析两组患者的治疗效果以及产后生活质量.结果 在出血量、止血时间、产后焦虑评分、抑郁评分等指标方面,观察组低于对照组,差异有统计学意义(P<0.05);在产后生活质量评分方面,观察组高于对照组,差异具有统计学意义(P<0.05);在不良反应发生情况方面,观察组和对照组差异无统计学意义.结论 重组人凝血因子Ⅶ、卡前列素胺丁三醇、心理干预治疗产后出血,临床疗效显著,能够较好的提高患者生活质量,改善患者的负面情绪,值得推广应用.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号